EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Antiviral and Anti-Inflammatory Activities of N-Acetylglucosamine: Development of an Alternative and Safe Approach to Fight Viral Respiratory Infections

Magda Marchetti iD, Barbara De Berardis iD, Irene Bigioni iD, Alessia Mariano iD, Fabiana Superti iD, Anna Scotto d'Abusco iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Magda Marchetti und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Innovative Technologies in Public Health, National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Influenza A Virus, H1N1 Subtype, COVID-19, Respiratory Tract Infections, Virus Diseases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Progetto POR FESR LAZIO-2014-2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral respiratory tract infections (RTIs) are responsible for significant morbidity and mortality worldwide. A prominent feature of severe respiratory infections, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is the cytokine release syndrome. Therefore, there is an urgent need to develop different approaches both against viral replication and against the consequent inflammation. N-acetylglucosamine (GlcNAc), a glucosamine (GlcN) derivative, has been developed as an immunomodulatory and anti-inflammatory inexpensive and non-toxic drug for non-communicable disease treatment and/or prevention. Recent studies have suggested that GlcN, due to its anti-inflammatory activity, could be potentially useful for the control of respiratory virus infections. Our present study aimed to evaluate in two different immortalized cell lines whether GlcNAc could inhibit or reduce both viral infectivity and the inflammatory response to viral infection. Two different viruses, frequent cause of upper and lower respiratory tract infections, were used: the H1N1 Influenza A virus (IAV) (as model of enveloped RNA virus) and the Human adenovirus type 2 (Adv) (as model of naked DNA virus). Two forms of GlcNAc have been considered, bulk GlcNAc and GlcNAc in nanoform to overcome the possible pharmacokinetic limitations of GlcNAc. Our study suggests that GlcNAc restricts IAV replication but not Adv infection, whereas nano-GlcNAc inhibits both viruses. Moreover, GlcNAc and mainly its nanoformulation were able to reduce the pro-inflammatory cytokine secretion stimulated by viral infection. The correlation between inflammatory and infection inhibition is discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza A Virus, H1N1 SubtypeCOVID-19Respiratory Tract InfectionsVirus DiseasesPneumoniaInfluenza A virusHumansAntiviral AgentsAcetylglucosamineSARS-CoV-2Anti-Inflammatory AgentsGlucosamineAdenoviridae

Stichwörter der Autor:innen

Influenza A virusN-acetylglucosamineadenovirusinflammationnanotechnologyviral respiratory infections

Substanzen

Antiviral AgentsAcetylglucosamineAnti-Inflammatory AgentsGlucosamine

Autor:innen und Institutionen

  • National Centre for Innovative Technologies in Public Health, National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy.
  • Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy.

ORCID-Profile: Magda Marchetti, Barbara De Berardis, Irene Bigioni, Alessia Mariano, Fabiana Superti, Anna Scotto d'Abusco

Förderung

  • Progetto POR FESR LAZIO-2014-2020

Zitieren

APA

Marchetti, M., De Berardis, B., Bigioni, I., Mariano, A., Superti, F., & Scotto d'Abusco, A. (2023). In Vitro Antiviral and Anti-Inflammatory Activities of N-Acetylglucosamine: Development of an Alternative and Safe Approach to Fight Viral Respiratory Infections. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065129

Vancouver

Marchetti M, De Berardis B, Bigioni I, Mariano A, Superti F, Scotto d'Abusco A. In Vitro Antiviral and Anti-Inflammatory Activities of N-Acetylglucosamine: Development of an Alternative and Safe Approach to Fight Viral Respiratory Infections. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065129

BibTeX
@article{Marchetti2023,
  author = {Marchetti, Magda and De Berardis, Barbara and Bigioni, Irene and Mariano, Alessia and Superti, Fabiana and Scotto d'Abusco, Anna},
  title = {In Vitro Antiviral and Anti-Inflammatory Activities of N-Acetylglucosamine: Development of an Alternative and Safe Approach to Fight Viral Respiratory Infections},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065129}
}
Kostenlos starten →